# Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

> clinical trial · VERIFIED · 2026-06-30

Status: RECRUITING · Sponsor: Abiomed Inc. · Condition: AMI Cardiogenic Shock

- Company: Abiomed Inc.
- Sector: medtech
- Primary source: https://clinicaltrials.gov/study/NCT06964685

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.